Novo A/S as of March 31, 2017
Portfolio Holdings for Novo A/S
Novo A/S holds 22 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Inogen (INGN) | 29.3 | $275M | 3.5M | 77.56 | |
| Anaptysbio Inc Common (ANAB) | 9.0 | $84M | 3.0M | 27.75 | |
| Reata Pharmaceuticals Inc Cl A | 8.1 | $76M | 3.4M | 22.65 | |
| Irhythm Technologies (IRTC) | 8.1 | $76M | 2.0M | 37.60 | |
| Corvus Pharmaceuticals (CRVS) | 7.1 | $67M | 3.2M | 20.77 | |
| Ra Pharmaceuticals | 4.6 | $43M | 2.0M | 21.29 | |
| Acceleron Pharma | 4.4 | $41M | 1.6M | 26.47 | |
| Flexion Therapeutics | 4.0 | $38M | 1.4M | 26.91 | |
| Spectranetics Corporation | 3.7 | $34M | 1.2M | 29.13 | |
| Merus N V (MRUS) | 3.7 | $34M | 1.4M | 24.39 | |
| Obseva Sa | 3.4 | $32M | 3.0M | 10.41 | |
| Nabriva Therapeutics | 3.0 | $28M | 2.3M | 12.00 | |
| Dermira | 2.7 | $26M | 748k | 34.11 | |
| Kalvista Pharmaceuticals (KALV) | 2.4 | $23M | 2.9M | 7.81 | |
| Apollo Endosurgery | 1.9 | $18M | 1.5M | 12.52 | |
| Akebia Therapeutics (AKBA) | 1.2 | $12M | 1.3M | 9.20 | |
| Invuity | 1.1 | $11M | 1.3M | 7.95 | |
| Htg Molecular Diagnostics | 0.9 | $8.9M | 1.3M | 6.92 | |
| Wright Medical Group Rtsn V | 0.8 | $7.1M | 4.6M | 1.53 | |
| Crispr Therapeutics (CRSP) | 0.5 | $4.9M | 223k | 21.77 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $510k | 128k | 4.00 | |
| Opko Health (OPK) | 0.0 | $2.0k | 259.00 | 7.72 |
